Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 483869, 11 pages
http://dx.doi.org/10.1155/2011/483869
Research Article

Development of Novel In Silico Model to Predict Corneal Permeability for Congeneric Drugs: A QSPR Approach

1Department of Ocular Pharmacology and Pharmacy, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110029, India
3Department of Ocular Microbiology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India
4Department of Cornea and Refractive Surgery, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India
5Department of Paediatric Ophthalmology & Oculoplasty, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India

Received 28 May 2010; Revised 7 September 2010; Accepted 26 October 2010

Academic Editor: Ayman El-Kadi

Copyright © 2011 Charu Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. S. Lesar and R. G. Fiscella, “Antimicrobial drug delivery to the eye,” Drug Intelligence and Clinical Pharmacy, vol. 19, no. 9, pp. 642–654, 1985. View at Google Scholar · View at Scopus
  2. E. Mannermaa, K. S. Vellonen, and A. Urtti, “Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics,” Advanced Drug Delivery Reviews, vol. 58, no. 11, pp. 1136–1163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Narayanan and S. B. Gunturi, “In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method,” Bioorganic and Medicinal Chemistry, vol. 13, no. 8, pp. 3017–3028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Shirasaki, “Molecular design for enhancement of ocular penetration,” Journal of Pharmaceutical Sciences, vol. 97, no. 7, pp. 2462–2496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 46, no. 1-3, pp. 3–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Velpandian, “Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies,” Expert Opinion on Drug Delivery, vol. 6, no. 3, pp. 255–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Chen and J. Yang, “MI-QSAR models for prediction of corneal permeability of organic compounds,” Acta Pharmacologica Sinica, vol. 27, no. 2, pp. 193–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Huang, R. D. Schoenwald, and J. L. Lach, “Corneal penetration behavior of β-blocking agents. III: in vitro-in vivo correlations,” Journal of Pharmaceutical Sciences, vol. 72, no. 11, pp. 1279–1281, 1983. View at Google Scholar · View at Scopus
  9. A. P. Worth and M. T. D. Cronin, “Structure-permeability relationships for transcorneal penetration,” ATLA Alternatives to Laboratory Animals, vol. 28, no. 3, pp. 403–413, 2000. View at Google Scholar · View at Scopus
  10. F. Yoshida and J. G. Topliss, “Unified model for the corneal permeability of related and diverse compounds with respect to their physicochemical properties,” Journal of Pharmaceutical Sciences, vol. 85, no. 8, pp. 819–823, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. X. C. Fu and W. Q. Liang, “A simple model for the prediction of corneal permeability,” International Journal of Pharmaceutics, vol. 232, no. 1-2, pp. 193–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. N. F. Smith, F. I. Raynaud, and P. Workman, “The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery,” Molecular Cancer Therapeutics, vol. 6, no. 2, pp. 428–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sarker and P. Workman, “Pharmacodynamic biomarkers for molecular cancer therapeutics,” Advances in Cancer Research, vol. 96, pp. 213–268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. I. Raynaud, P. M. Fischer, B. P. Nutley, P. M. Goddard, D. P. Lane, and P. Workman, “Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis,” Molecular Cancer Therapeutics, vol. 3, no. 3, pp. 353–362, 2004. View at Google Scholar · View at Scopus
  15. V. P. Ranta, E. Toropainen, A. Talvitie, S. Auriola, and A. Urtti, “Simultaneous determination of eight β-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro,” Journal of Chromatography B, vol. 72, no. 1, pp. 81–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Kadam and U. B. Kompella, “Cassette analysis of eight beta-blockers in bovine eye sclera, choroid-RPE, retina, and vitreous by liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B, vol. 877, no. 3, pp. 253–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. W. Proksch and K. W. Ward, “Cassette dosing pharmacokinetic studies for evaluation of ophthalmic drugs for posterior ocular diseases,” Journal of Pharmaceutical Sciences, vol. 97, no. 8, pp. 3411–3421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Hecht, “Ophthalmic preparations,” in Remington-The Science and Practice of Pharmacy, A. R. Gebbari, Ed., p. 1563, Mack Publishing, Pittsburgh, Pa, USA, 19th edition, 1995. View at Google Scholar
  19. A. M. Thompson, “Ocular toxicity of fluoroquinolones,” Clinical and Experimental Ophthalmology, vol. 35, no. 6, pp. 566–577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Civiale, F. Bucaria, S. Piazza, O. Peri, F. Miano, and V. Enea, “Ocular permeability screening of dexamethasone esters through combined cellular and tissue systems,” Journal of Ocular Pharmacology and Therapeutics, vol. 20, no. 1, pp. 75–84, 2004. View at Google Scholar · View at Scopus
  21. G. S. Tirucherai, C. Dias, and A. K. Mitra, “Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design,” Journal of Ocular Pharmacology and Therapeutics, vol. 18, no. 6, pp. 535–548, 2002. View at Google Scholar · View at Scopus
  22. P. Suhonen, T. Järvinen, S. Koivisto, and A. Urtti, “Different effects of pH on the permeation of pilocarpine and pilocarpine prodrugs across the isolated rabbit cornea,” European Journal of Pharmaceutical Sciences, vol. 6, no. 3, pp. 169–176, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Mitra and T. J. Mikkelson, “Mechanism of transcorneal permeation of pilocarpine,” Journal of Pharmaceutical Sciences, vol. 77, no. 9, pp. 771–775, 1988. View at Google Scholar · View at Scopus
  24. N. L. Burstein and J. A. Anderson, “Corneal penetration and ocular bioavailability of drugs,” Journal of Ocular Pharmacology, vol. 1, no. 3, pp. 309–326, 1985. View at Google Scholar · View at Scopus
  25. M. B. Santillán, F. Tomás-Vert, J. M. Aulló, E. A. Jáuregui, and G. M. Ciuffo, “Structural and electronic properties of tyrosine kinases inhibitors,” Cellular and Molecular Biology, vol. 49, no. 6, pp. 929–937, 2003. View at Google Scholar · View at Scopus
  26. M. Yoshida and J. I. Aihara, “Validity of the weighted HOMO-LUMO energy separation as an index of kinetic stability for fullerenes with up to 120 carbon atoms,” Physical Chemistry Chemical Physics, vol. 1, no. 2, pp. 227–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. LU. Xu, J. A. Yang, and YA. P. Wu, “Effective descriptions of molecular structures and the quantitative structure—activity relationship studies,” Journal of Chemical Information and Computer Sciences, vol. 42, no. 3, pp. 602–606, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Fernandes and C. R. Gattass, “Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1),” Journal of Medicinal Chemistry, vol. 52, no. 4, pp. 1214–1218, 2009. View at Publisher · View at Google Scholar · View at Scopus